V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 200006611 | 200018499 | null | null | null | null | 2022-04-04 | null | null | null | IPILIMUMAB | 100452809 |
| 200006617 | 200018500 | 1.68 | 81.5 | 03 | null | 2020-05-11 | null | null | N | TRIAL UNSPECIFIED | 100259956 |
| 200006624 | 200018501 | null | null | null | null | 2017-09-28 | null | null | null | DABRAFENIB | 100769048 |
| 200006626 | 200018502 | null | null | null | null | 2022-04-26 | null | null | null | IPILIMUMAB + NIVOLUMAB | 101763571 |
| 200006629 | 200018503 | null | null | null | 2017-01-27 | 2017-07-27 | null | null | null | IPILIMUMAB | 100644897 |
| 200006631 | 200018504 | 1.84 | 80 | Palliative (P) | 2019-01-25 | 2019-02-17 | Ipilimumab | 02 | N | IPILIMUMAB | 101798152 |
| 200006637 | 200018505 | 1.76 | 61.7 | Palliative (P) | 2019-06-12 | 2019-06-26 | null | 02 | null | IPILIMUMAB + NIVOLUMAB | 101640934 |
| 200006668 | 200018509 | null | null | null | null | 2020-09-19 | null | null | null | BINIMETINIB + ENCORAFENIB | 101787593 |
| 200006670 | 200018510 | null | 126 | Palliative (P) | 2017-09-28 | 2019-06-25 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100017727 |
| 200006688 | 200018514 | 1.64 | null | null | null | 2019-12-04 | null | null | null | BINIMETINIB + ENCORAFENIB | 101136617 |
| 200006699 | 200018517 | 1.76 | 98.6 | Palliative (P) | null | 2017-08-10 | null | null | null | DABRAFENIB | 101433039 |
| 200006704 | 200018518 | 1.68 | null | null | null | 2020-05-01 | null | null | null | TRIAL UNSPECIFIED | 101042159 |
| 200006716 | 200018520 | 1.52 | 56 | Palliative (P) | null | 2021-10-29 | null | null | null | BINIMETINIB + ENCORAFENIB | 101121717 |
| 200006717 | 200018521 | null | 76.5 | 03 | null | 2021-06-10 | null | null | N | IPILIMUMAB | 100821455 |
| 200006722 | 200018522 | 1.61 | null | null | null | 2019-10-07 | null | null | null | DABRAFENIB | 101139303 |
| 200006746 | 200018524 | null | null | null | null | 2019-04-07 | null | null | null | CISPLATIN + FLUOROURACIL | 101583953 |
| 200006777 | 200018527 | null | 66.2 | Adjuvant (A) | 2021-07-25 | 2021-07-27 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100993796 |
| 200006782 | 200018528 | 1.86 | 72 | Palliative (P) | null | 2019-06-13 | null | null | N | IPILIMUMAB | 100378971 |
| 200006790 | 200018530 | 1.7 | 87.4 | Palliative (P) | null | 2021-12-11 | null | null | N | DABRAFENIB | 101176501 |
| 200006798 | 200018531 | 1.64 | 86 | Palliative (P) | null | 2021-10-19 | null | null | N | IPILIMUMAB + NIVOLUMAB | 100054761 |
| 200006803 | 200018532 | 1.81 | null | null | null | 2019-11-15 | null | null | null | FULVESTRANT + PALBOCICLIB | 100658788 |
| 200006806 | 200018534 | 1.6 | 76 | Palliative (P) | 2019-08-15 | 2019-09-02 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100783481 |
| 200006809 | 200018535 | null | 81.4 | Palliative (P) | null | 2020-08-10 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100952719 |
| 200006816 | 200018537 | 1.64 | null | null | null | 2020-11-19 | null | null | null | TEMOZOLOMIDE | 101424806 |
| 200006820 | 200018538 | 1.56 | 87 | Palliative (P) | 2019-11-08 | 2019-11-15 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100675217 |
| 200006834 | 200018539 | 1.8 | 69.5 | Palliative (P) | 2021-05-28 | 2021-06-07 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100985242 |
| 200006849 | 200018541 | 1.9 | 89.8 | Palliative (P) | null | 2017-10-02 | null | null | null | INTERIM TRIAL | 100357303 |
| 200006866 | 200018546 | null | 67.5 | Palliative (P) | null | 2019-04-29 | null | null | null | IPILIMUMAB + NIVOLUMAB | 100127476 |
| 200006878 | 200018548 | 1.87 | 90 | Palliative (P) | null | 2017-12-11 | null | null | N | BINIMETINIB + ENCORAFENIB | 100414722 |
| 200006883 | 200018549 | 1.73 | null | null | null | 2022-03-22 | null | null | null | IPILIMUMAB | 100007544 |
| 200006888 | 200018552 | 1.73 | null | null | null | 2017-03-07 | null | null | null | BINIMETINIB + ENCORAFENIB | 101465525 |
| 200006904 | 200018553 | 1.61 | null | null | null | 2022-03-06 | null | null | null | TRIAL UNSPECIFIED | 101224939 |
| 200006905 | 200018554 | null | 64.3 | Adjuvant (A) | null | 2018-05-09 | null | null | N | DACARBAZINE | 100679217 |
| 200006912 | 200018555 | null | 73.7 | Palliative (P) | null | 2021-10-27 | null | null | null | TRIAL | 101279586 |
| 200006922 | 200018557 | 1.58 | 83.3 | 03 | null | 2020-01-06 | null | null | N | BINIMETINIB + ENCORAFENIB | 100467968 |
| 200006950 | 200018561 | 1.81 | 99.45 | Palliative (P) | null | 2022-03-17 | null | null | null | TRIAL UNSPECIFIED | 100777240 |
| 200006967 | 200018564 | 1.68 | 78.4 | Palliative (P) | null | 2019-02-11 | null | null | N | TRIAL | 100702320 |
| 200006973 | 200018565 | 1.6 | null | null | null | 2021-03-27 | null | null | null | TRIAL UNSPECIFIED | 100652588 |
| 200006993 | 200018570 | null | null | null | null | 2019-02-09 | null | null | null | TRIAL | 101285267 |
| 200006994 | 200018571 | null | 85.5 | Palliative (P) | null | 2018-01-15 | null | null | null | TRIAL UNSPECIFIED | 101564350 |
| 200000117 | 200018572 | 1.66 | null | null | null | 2018-11-29 | null | null | null | TRIAL UNSPECIFIED | 100271704 |
| 200000192 | 200018574 | 1.7 | 0 | 03 | 2020-02-14 | 2020-03-14 | null | 02 | null | IPILIMUMAB + NIVOLUMAB | 101248170 |
| 200000521 | 200018577 | null | 78.4 | 03 | null | 2017-04-30 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100245605 |
| 200000618 | 200018579 | 1.74 | 97.1 | Palliative (P) | 2020-06-13 | 2020-06-18 | null | 02 | null | IPILIMUMAB | 100675799 |
| 200001154 | 200018582 | 1.74 | 103.4 | Palliative (P) | 2020-02-21 | 2020-03-01 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100435032 |
| 200001637 | 200018585 | 1.73 | 70.8 | Palliative (P) | 2019-01-31 | 2019-02-12 | Binimetinib + Encorafenib | 02 | N | BINIMETINIB + ENCORAFENIB | 100950580 |
| 200001766 | 200018587 | 1.62 | 69.35 | Palliative (P) | 2019-03-06 | 2019-03-13 | Ipilimumab | null | N | IPILIMUMAB | 101279198 |
| 200002361 | 200018591 | 1.7 | 65.6 | Palliative (P) | null | 2020-07-17 | null | null | null | BINIMETINIB + ENCORAFENIB | 100126973 |
| 200002664 | 200018592 | null | null | null | null | 2019-12-12 | null | null | null | TRIAL UNSPECIFIED | 100935981 |
| 200003137 | 200018593 | 1.71 | null | null | null | 2019-05-18 | null | null | null | BINIMETINIB + ENCORAFENIB | 100990498 |